US 10683347
Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies
granted A61KA61K2039/507A61K2039/57
Quick answer
US patent 10683347 (Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies) held by The Regents of the University of California expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/507, A61K2039/57, A61P, A61P35/00